Literature DB >> 23558684

Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43).

Akemi Shodai1, Toshifumi Morimura, Akemi Ido, Tsukasa Uchida, Takashi Ayaki, Rina Takahashi, Soichiro Kitazawa, Sakura Suzuki, Mikako Shirouzu, Takanori Kigawa, Yutaka Muto, Shigeyuki Yokoyama, Ryosuke Takahashi, Ryo Kitahara, Hidefumi Ito, Noriko Fujiwara, Makoto Urushitani.   

Abstract

Aggregation of TAR DNA-binding protein of 43 kDa (TDP-43) is a pathological signature of amyotrophic lateral sclerosis (ALS). Although accumulating evidence suggests the involvement of RNA recognition motifs (RRMs) in TDP-43 proteinopathy, it remains unclear how native TDP-43 is converted to pathogenic forms. To elucidate the role of homeostasis of RRM1 structure in ALS pathogenesis, conformations of RRM1 under high pressure were monitored by NMR. We first found that RRM1 was prone to aggregation and had three regions showing stable chemical shifts during misfolding. Moreover, mass spectrometric analysis of aggregated RRM1 revealed that one of the regions was located on protease-resistant β-strands containing two cysteines (Cys-173 and Cys-175), indicating that this region served as a core assembly interface in RRM1 aggregation. Although a fraction of RRM1 aggregates comprised disulfide-bonded oligomers, the substitution of cysteine(s) to serine(s) (C/S) resulted in unexpected acceleration of amyloid fibrils of RRM1 and disulfide-independent aggregate formation of full-length TDP-43. Notably, TDP-43 aggregates with RRM1-C/S required the C terminus, and replicated cytopathologies of ALS, including mislocalization, impaired RNA splicing, ubiquitination, phosphorylation, and motor neuron toxicity. Furthermore, RRM1-C/S accentuated inclusions of familial ALS-linked TDP-43 mutants in the C terminus. The relevance of RRM1-C/S-induced TDP-43 aggregates in ALS pathogenesis was verified by immunolabeling of inclusions of ALS patients and cultured cells overexpressing the RRM1-C/S TDP-43 with antibody targeting misfolding-relevant regions. Our results indicate that cysteines in RRM1 crucially govern the conformation of TDP-43, and aberrant self-assembly of RRM1 at amyloidogenic regions contributes to pathogenic conversion of TDP-43 in ALS.

Entities:  

Keywords:  Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease); Cell Biology; Protein Chemical Modification; Protein Misfolding; Structural Biology; TAR DNA-binding Protein 43 kDa

Mesh:

Substances:

Year:  2013        PMID: 23558684      PMCID: PMC3663511          DOI: 10.1074/jbc.M113.451849

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Modulation of prion protein structure by pressure and temperature.

Authors:  Joan Torrent; Maria Teresa Alvarez-Martinez; Jean-Pierre Liautard; Reinhard Lange
Journal:  Biochim Biophys Acta       Date:  2005-11-15

2.  TDP-43 neurotoxicity and protein aggregation modulated by heat shock factor and insulin/IGF-1 signaling.

Authors:  Tao Zhang; Patrick C Mullane; Goran Periz; Jiou Wang
Journal:  Hum Mol Genet       Date:  2011-02-25       Impact factor: 6.150

3.  Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking.

Authors:  Todd J Cohen; Andrew W Hwang; Travis Unger; John Q Trojanowski; Virginia M Y Lee
Journal:  EMBO J       Date:  2011-12-23       Impact factor: 11.598

Review 4.  TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies.

Authors:  Todd J Cohen; Virginia M Y Lee; John Q Trojanowski
Journal:  Trends Mol Med       Date:  2011-07-23       Impact factor: 11.951

5.  RNA targets of TDP-43 identified by UV-CLIP are deregulated in ALS.

Authors:  Shangxi Xiao; Teresa Sanelli; Samar Dib; David Sheps; Joseph Findlater; Juan Bilbao; Julia Keith; Lorne Zinman; Ekaterina Rogaeva; Janice Robertson
Journal:  Mol Cell Neurosci       Date:  2011-03-21       Impact factor: 4.314

6.  Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Masato Hasegawa; Tetsuaki Arai; Takashi Nonaka; Fuyuki Kametani; Mari Yoshida; Yoshio Hashizume; Thomas G Beach; Emanuele Buratti; Francisco Baralle; Mitsuya Morita; Imaharu Nakano; Tatsuro Oda; Kuniaki Tsuchiya; Haruhiko Akiyama
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

7.  Hot spots in prion protein for pathogenic conversion.

Authors:  Kazuo Kuwata; Noriyuki Nishida; Tomoharu Matsumoto; Yuji O Kamatari; Junji Hosokawa-Muto; Kota Kodama; Hironori K Nakamura; Kiminori Kimura; Makoto Kawasaki; Yuka Takakura; Susumu Shirabe; Jiro Takata; Yasufumi Kataoka; Shigeru Katamine
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-06       Impact factor: 11.205

8.  Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).

Authors:  Eva Bentmann; Manuela Neumann; Sabina Tahirovic; Ramona Rodde; Dorothee Dormann; Christian Haass
Journal:  J Biol Chem       Date:  2012-05-04       Impact factor: 5.157

9.  Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice.

Authors:  Lionel M Igaz; Linda K Kwong; Edward B Lee; Alice Chen-Plotkin; Eric Swanson; Travis Unger; Joe Malunda; Yan Xu; Matthew J Winton; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 14.808

10.  Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9.

Authors:  E Buratti; F E Baralle
Journal:  J Biol Chem       Date:  2001-07-24       Impact factor: 5.157

View more
  26 in total

1.  Detection of TDP-43 oligomers in frontotemporal lobar degeneration-TDP.

Authors:  Patricia F Kao; Yun-Ru Chen; Xiao-Bo Liu; Charles DeCarli; William W Seeley; Lee-Way Jin
Journal:  Ann Neurol       Date:  2015-06-30       Impact factor: 10.422

2.  An ALS-mutant TDP-43 neurotoxic peptide adopts an anti-parallel β-structure and induces TDP-43 redistribution.

Authors:  Li Zhu; Meng Xu; Mengxue Yang; Yanlian Yang; Yang Li; Jianwen Deng; Linhao Ruan; Jianghong Liu; Sidan Du; Xuehui Liu; Wei Feng; Kazuo Fushimi; Eileen H Bigio; Marsel Mesulam; Chen Wang; Jane Y Wu
Journal:  Hum Mol Genet       Date:  2014-08-11       Impact factor: 6.150

3.  S-nitrosylated TDP-43 triggers aggregation, cell-to-cell spread, and neurotoxicity in hiPSCs and in vivo models of ALS/FTD.

Authors:  Elaine Pirie; Chang-Ki Oh; Xu Zhang; Xuemei Han; Piotr Cieplak; Henry R Scott; Amanda K Deal; Swagata Ghatak; Fernando J Martinez; Gene W Yeo; John R Yates; Tomohiro Nakamura; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

4.  Folding of the RNA recognition motif (RRM) domains of the amyotrophic lateral sclerosis (ALS)-linked protein TDP-43 reveals an intermediate state.

Authors:  Brian C Mackness; Meme T Tran; Shannan P McClain; C Robert Matthews; Jill A Zitzewitz
Journal:  J Biol Chem       Date:  2014-02-04       Impact factor: 5.157

Review 5.  Examining the relationship between astrocyte dysfunction and neurodegeneration in ALS using hiPSCs.

Authors:  Madeline Halpern; Kristen J Brennand; James Gregory
Journal:  Neurobiol Dis       Date:  2019-08-02       Impact factor: 5.996

6.  Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS.

Authors:  Kaitlin Weskamp; Elizabeth M Tank; Roberto Miguez; Jonathon P McBride; Nicolás B Gómez; Matthew White; Ziqiang Lin; Carmen Moreno Gonzalez; Andrea Serio; Jemeen Sreedharan; Sami J Barmada
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

Review 7.  Multi-phaseted problems of TDP-43 in selective neuronal vulnerability in ALS.

Authors:  Kazuhide Asakawa; Hiroshi Handa; Koichi Kawakami
Journal:  Cell Mol Life Sci       Date:  2021-03-11       Impact factor: 9.261

Review 8.  The Link between Oxidative Stress, Redox Status, Bioenergetics and Mitochondria in the Pathophysiology of ALS.

Authors:  Elena Obrador; Rosario Salvador-Palmer; Rafael López-Blanch; Ali Jihad-Jebbar; Soraya L Vallés; José M Estrela
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

Review 9.  Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders.

Authors:  Jonathan Janssens; Christine Van Broeckhoven
Journal:  Hum Mol Genet       Date:  2013-07-29       Impact factor: 6.150

Review 10.  Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS.

Authors:  Maria Teresa Carrì; Cristiana Valle; Francesca Bozzo; Mauro Cozzolino
Journal:  Front Cell Neurosci       Date:  2015-02-17       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.